Idea Density in Exam Performance (IDEP)

October 9, 2023 updated by: Andrew Lunn, Liverpool John Moores University

Impact of Reduced Idea Density on Pharmacy Students' Attainment in Pharmaceutical Calculations: a Single-blind Multicentre Randomised Controlled Trial

Text can be written in multiple ways to mean the same thing; changing how a text is written can make it easier or harder to understand. How many concepts or ideas there are in a text, divided by the total number of words, is one possible way to determine how easy or hard it is to understand. This ratio is called idea density (ID).

Varying ID has been shown to affect the speed at which a reader understands; it impacts certain people more than others, such as second language speakers. This effect may be of particular importance in an exam, where understanding a question in a limited time is key. In the UK, pharmacy students must undertake an exam set by the General Pharmaceutical Council (GPhC) to be registered as pharmacists. The exam involves pharmaceutical calculations and shows variable pass rates. This study aims to evaluate the impact of reducing ID in a pharmaceutical calculation test and will be conducted in 14 schools of pharmacy in the UK. All participants will take a GPhC style test. Then, participants will be divided into two groups of equal size; one group will undertake a second test with the same ID as the first, while the second group will undertake a test with a lower ID. Finally, the investigators will compare the second test scores between the two groups as cohorts and question by question, evaluating whether lowering ID has increased students' scores.

If and effect is seen, ensuring that questions are written with a controlled ID may help ensure we are examining more fairly and allowing students with the requisite knowledge to pass.

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

Pharmaceutical Council must be undertaken. It involves pharmaceutical calculations and shows variable pass rates. Linguistic factors, such as idea density, affect and predict comprehension time. This trial will evaluate the effect of lowering question idea density on attainment in a pharmaceutical calculations exam aligned to that of the General Pharmaceutical Council.

Methods: This is a single-blind, parallel 2-arm multicentre randomised controlled trial conducted in fourteen Universities across the United Kingdom. A 1:1 randomisation and a sample size of 188 pharmacy students will be sufficient to detect a 1-point difference in the mean scores between the intervention and control group during a pharmacy calculation test with two-tails, 80% power and 5% significance level. Each school will recruit a minimum of 14/15 students. Participants will sit two 12-question pharmaceutical calculation tests. All participants will take the same baseline test; then, will be randomised and undertake a second test 2-week after, with standard idea density for the control group and lower idea density for the intervention. Primary outcome: the scores obtained by the participants undertaking the second calculation test 2-week after the baseline. Secondary outcomes: percentage of students achieving a pass during the second test; effect of demographic characteristics (first or not-first English language speakers, age, ethnicity, year of study, specific learning disability) on participants' attainment when lowering idea density.

Conclusion: Results could inform the development of new standards in the pharmaceutical calculations exam.

Study Type

Interventional

Enrollment (Actual)

204

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • Merseyside
      • Liverpool, Merseyside, United Kingdom, L3 3AF
        • Liverpool John Moores University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Over 18 years of age
  • Registered as a student on an MPharm course in the UK
  • Be in years 1-4 of the course (levels 1-7)

Exclusion Criteria:

  • Under 18
  • Not registered on an MPharm course in the UK
  • Are currently undertaking a foundation year (level 3)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: Control
Participants in the control group will receive an initial 12 question baseline test (same as intervention). They will after two weeks receive a second test that is linguistically the same as the national GPhC exam.
Experimental: Intervention
Participants in the intervention group will receive an initial 12 question baseline test (same as control). They will after two weeks receive a second test that is reduced in idea density by around 10% overall.
Question idea density reduced (ratio of propositions to total words used).

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Overall performance on test 2
Time Frame: 1 month
The primary outcome is the performance in the second calculation test 2. Overall score per student can be between 0-12, and performance of all students on each question a decimal percent between 0-1, with 0 meaning 0% of students answered correctly and 1 meaning 100% of students answered correctly.
1 month

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Pass rate
Time Frame: 1 month
The percentage of students achieving a pass (equivalent to 70% or above) during the second test.
1 month
Demographic
Time Frame: 1 month

The effect of each demographic characteristic on students' attainment in pharmacy calculation when lowering idea density?

  • First language speaker (English as the first language) or not
  • Age
  • Ethnicity
  • Year of study
  • Specific learning disability
1 month

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 3, 2022

Primary Completion (Actual)

November 6, 2022

Study Completion (Actual)

December 6, 2022

Study Registration Dates

First Submitted

August 31, 2022

First Submitted That Met QC Criteria

September 1, 2022

First Posted (Actual)

September 2, 2022

Study Record Updates

Last Update Posted (Estimated)

October 10, 2023

Last Update Submitted That Met QC Criteria

October 9, 2023

Last Verified

October 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • 22/PBS/004

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

Study protocol to be published Original (anonymised) data to be placed on university repository

IPD Sharing Time Frame

Within 1 year of study (when published), indefinitely available on university repository

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Medical Education

Clinical Trials on Reduced Idea Density

3
Subscribe